Centre moves to tighten controls on antibiotic manufacturing, bulk drug trade
<a href="https://timesofindia.indiatimes.com/india/centre-moves-to-tighten-controls-on-antibiotic-manufacturing-bulk-drug-trade/articleshow/136017617.cms"><img align="left" border="0" hspace="10" src="https://timesofindia.indiatimes.com/photo/136017617.cms" style="margin-top: 3px; margin-right: 5px;" /></a>The Centre plans to introduce stringent regulations on antibiotic manufacturing and distribution as a strategy to counteract antimicrobial resistance. Newly proposed measures require manufacturers to secure central approval for antimicrobial licenses, coupled with enhanced quality assessments. Wholesalers will also need distinct licenses for bulk drugs, promoting improved monitoring. Stakeholders are encouraged to provide public comments on these draft amendments prior to their finalization.
Balanced coverage
1 outlet covering this story
No AI summary generated for this bucket yet.
1 Article
- Center
Discussion (0)
- No comments yet — be the first to weigh in.
